A novel splice site mutation in the SPG7 gene causing widespread fiber damage in homozygous and heterozygous subjects.
Hereditary spastic paraplegias (HSP) are genetically and clinically heterogeneous neurodegenerative disorders. The purpose of this study was to assess the genotype and phenotype in a family with a complicated form of autosomal recessive hereditary spastic paraplegia (ARHSP). Neurological and neuropsychological evaluation, neurophysiologic studies, fiberoptic endoscopic evaluation of swallowing (FEES), neuroimaging analysis including diffusion tensor imaging (DTI), and mutation analysis of SPG4 and SPG7 gene were performed. The index case (mother) was affected by an adult-onset form of complicated ARHSP due to the homozygous splice site mutation c.1552+1 G>T in the SPG7 gene. This mutation leads to an abnormally spliced mRNA lacking exon 11. Additional clinical features were bilateral ptosis and subtle deficits in executive function. All three asymptomatic daughters carried the sequence variation c.1552+1 G>T in heterozygous state. DTI of the mother revealed disturbance of white matter (WM) integrity in the left frontal lobe, the left corticospinal tract and both sides of the brainstem. DTI of the daughters showed subtle WM alteration in the frontal corpus callosum. The novel mutation is the first splice site mutation found in the SPG7 gene. It removes part of the AAA domain of paraplegin protein, probably leading to a loss-of-function of the paraplegin-AFG3L2 complex in the mitochondrial inner membrane. The pattern of WM damage in the homozygote index case may be specific for SPG7-HSP. The detection of cerebral WM alterations in the corpus callosum of asymptomatic heterozygote carriers confirms this brain region as the most prominent and early location of fiber damage in ARHSP.
Warnecke
Tobias
T
Department of Neurology, University Hospital of Münster, Münster, Germany.
Duning
Thomas
T
Schirmacher
Anja
A
Mohammadi
Siawoosh
S
Schwindt
Wolfram
W
Lohmann
Hubertus
H
Dziewas
Rainer
R
Deppe
Michael
M
Ringelstein
E Bernd
EB
Young
Peter
P
D000074183:ATPases Associated with Diverse Cellular Activities; D000328:Adult; D019943:Amino Acid Substitution / Q000235:genetics; D001284:Atrophy / Q000235:genetics / Q000473:pathology; D001921:Brain / Q000473:pathology*; D004252:DNA Mutational Analysis; D004274:DNA, Recombinant / Q000235:genetics*; D038524:Diffusion Magnetic Resonance Imaging; D004568:Electrodiagnosis; D005260:Female; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D005838:Genotype; D006801:Humans; D008666:Metalloendopeptidases / Q000235:genetics*; D008875:Middle Aged; D018485:Muscle Fibers, Skeletal / Q000473:pathology*; D009434:Neural Pathways / Q000473:pathology; D009483:Neuropsychological Tests; D010641:Phenotype; D017354:Point Mutation / Q000235:genetics; D015419:Spastic Paraplegia, Hereditary / Q000235:genetics*; D014429:Twins, Dizygotic / Q000235:genetics*; D014430:Twins, Monozygotic / Q000235:genetics*
D004274:DNA, Recombinant; D008666:Metalloendopeptidases; C112889:SPG7 protein, human; D000074183:ATPases Associated with Diverse Cellular Activities